Try our beta test site
17 studies found for:    Open Studies | "Restless Legs Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Restless Legs Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome
Condition: Restless Legs Syndrome
Interventions: Device: MMF07 Foot Massager;   Device: Heat Therapy
2 Not yet recruiting A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
Condition: Restless Legs Syndrome (RLS)
Interventions: Drug: Gabapentin enacarbil;   Drug: Placebo
3 Not yet recruiting Vitamin D in the Treatment of Primary Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Vitamin D
4 Recruiting An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Condition: RLS
Interventions: Drug: HORIZANT 300 mg;   Drug: HORIZANT 600 mg;   Drug: Placebo
5 Recruiting An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS
Condition: RLS
Intervention: Drug: HORIZANT 600 mg
6 Recruiting A Pharmacokinetic and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
Condition: RLS
Intervention: Drug: HORIZANT 300 mg
7 Not yet recruiting Effects of Gabapentin Enacarbil on Arousals, Heart Rate, Blood Pressure and PLMs in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Gabapentin Enacarbil (GEn);   Drug: Placebo
8 Not yet recruiting Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Condition: Restless Legs Syndrome (RLS)
Interventions: Drug: Injectafer® (Ferric Carboxymaltose - FCM);   Drug: Placebo (Normal Saline)
9 Recruiting The Effect of Horizant (Gabapentin Enacarbil) on Augmentation
Condition: Restless Legs Syndrome
Intervention: Drug: Horizant
10 Not yet recruiting Analysis of Sympathetic Activity in Willis-Ekbom Disease
Conditions: Willis-Ekbom Disease;   Restless Legs Syndrome
Intervention: Other: Sympathetic nervous activity measurement
11 Recruiting Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
Conditions: Restless Legs Syndrome;   Iron Deficiency Anemia
Interventions: Drug: Ferumoxytol intravenous;   Drug: Ferrous sulfate
12 Recruiting Specified Drug Use-Results Survey of Regnite
Condition: Restless Legs Syndrome
Intervention: Drug: Regnite
13 Not yet recruiting Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Gabapentin Enacarbil;   Drug: Placebo Oral Tablet
14 Recruiting Infra-slow Oscillations During Sleep
Conditions: Healthy Subjects;   Restless Legs Syndrome;   Periodic Limb Movements During Sleep
Intervention: Other: Acute sleep deprivation
15 Not yet recruiting Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
Conditions: Restless Leg Disorder;   Renal Disease Bone;   Renal Disease, End Stage;   Hyperparathyroidism, Secondary;   Adynamic Bone Disease;   Vitamin D Deficiency
Interventions: Drug: Vitamin D;   Drug: Placebo Oral Tablet
16 Recruiting Sleep Deficiency and Stroke Outcome
Conditions: Sleep Apnea Syndromes;   Sleep Initiation and Maintenance Disorders;   Insomnia;   Restless Legs Syndrome;   Stroke
Intervention:
17 Not yet recruiting Validating the Use of a Subjectively Reported Sleep Vital Sign
Conditions: Obstructive Sleep Apnea (OSA);   Insomnia;   Restless Leg Syndrome (RLS);   Hypersomnia Type; Sleep Disorder;   Shift Work Sleep Disorders
Intervention: Other: Sleep VS

Study has passed its completion date and status has not been verified in more than two years.